EN DE
STOCK COMPARISON

Brooker Group Public Company vs Vertex Pharmaceuticals: Fair Value & Quality

Both stocks run through our valuation models. Here is how Brooker Group Public Company (BTC) and Vertex Pharmaceuticals (VRTX) compare, as of Sep 6, 2026.

As of Sep 6, 2026, Fair Value Calculator sees Brooker Group Public Company as the less overvalued of the two: Brooker Group Public Company trades at THB 0.30 versus a fair value of THB 0.29 (-3%), while Vertex Pharmaceuticals trades at $546 versus $279 (-49%).
Brooker Group Public Company
BTC.BK · THB · Materials
-3%
upside to fair value
fairly valued
PriceTHB 0.30
Fair ValueTHB 0.29
Quality27/100
Vertex Pharmaceuticals
VRTX · USD · Health Care
-49%
upside to fair value
overvalued
Price$546
Fair Value$279
Quality79/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Brooker Group Public CompanyVertex Pharmaceuticals
Valuation
—P/E (TTM)28.8×
0.23×P/S (TTM)10.06×
—P/B6.59×
—EV/EBITDA23.8×
0.29×PEG1.72×
−3.3%Fair value upside−49.0%
15.0%Dividend yield0.1%
Profitability
—Operating margin38%
—EBIT margin trend (5Y)0.86×
-20%Return on equity24%
-10%Return on assets12%
Growth
-46%Revenue growth (YoY)8%
3.6%Avg. growth/yr (3Y)10.6%
—Avg. growth/yr (5Y)14.2%
—Value creation/yr+13.6%
Balance & size
—Interest coverage (EBIT/interest)357.9×
—Debt / equity0.03×
$53MMarket cap$123B
mixedGrowth qualityhealthy
Valuation multiples (P/E, P/S, P/B, EV/EBITDA) are shown but not scored here: the two companies sit in different sectors, and multiples only compare fairly between similar business models. PEG stays scored, as it relates the P/E to growth.

Even match: 3 to 3 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Brooker Group Public Companyof which business quality 28 · market factors 51 Vertex Pharmaceuticalsof which business quality 77 · market factors 78
ProfitabilityMargins and returns on capital today
0
72
Quality GrowthAre margins and returns improving?
9
65
CashflowEarnings quality: real cash, not paper profit
0
79
Fin. StrengthBalance sheet, leverage, solvency risk
69
92
InvestmentDisciplined investing over empire-building
97
58
Low VolatilityCalm price path (market factor)
50
85
MomentumPrice trend over the last 3–12 months (market factor)
59
67
52W MomentumDistance to the 52-week high (market factor)
41
88
Net IssuanceBuybacks instead of dilution
14
82

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyBrooker Group Public CompanyPrice THB 0.30Vertex PharmaceuticalsPrice $546
DCF Modelsn/a-17%below the price$453
Earnings-Basedn/a-6%close to the price$516
Dividend Discount0%close to the priceTHB 0.30-99%below the price$7.07
Multiplesn/a-49%below the price$278
Asset-Based-50%below the priceTHB 0.15-91%below the price$49.27
Growth DCFn/a-36%below the price$348
Economic Profitn/a-53%below the price$254
Growth Earningsn/a+27%above the price$692
Minimum-50%below the priceTHB 0.15-99%below the price$7.07
Maximum0%close to the priceTHB 0.30+27%above the price$692
Median-25%below the priceTHB 0.23-43%below the price$313
Geometric mean-29%below the priceTHB 0.21-66%below the price$185

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

Brooker Group Public Company: 2 of 3 models see the stock below the current price.

Vertex Pharmaceuticals: 22 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Brooker Group Public Company
Bear THB 0.17Fair Value THB 0.29Bull THB 0.39
THB 0.30 = current price (white tick)
Vertex Pharmaceuticals
Bear $210Fair Value $279Bull $900
$546 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Brooker Group Public Company · Materials

Quality score27 · bottom 25%
Fair value upside-3% · above median

Vertex Pharmaceuticals · Health Care

Quality score79 · Top 25%
Fair value upside-49% · below median

Bottom line

As of Sep 6, 2026, Fair Value Calculator sees Brooker Group Public Company as the less overvalued of the two: Brooker Group Public Company trades at THB 0.30 versus a fair value of THB 0.29 (-3%), while Vertex Pharmaceuticals trades at $546 versus $279 (-49%).

Vertex Pharmaceuticals has the higher quality score (79/100).

See the full analysis →
Brooker Group Public Company · Vertex Pharmaceuticals

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Brooker Group Public Company

Alphabet Inc Class C vs Verizon CommunicationsAlphabet Inc Class C vs At&tAlphabet Inc Class C vs NetEaseAmazon.com vs PDD Holdings

Related to Vertex Pharmaceuticals

Eli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth GroupMerck & Company vs UnitedHealth Group
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.